Status:
COMPLETED
Development and Validation of Pediatric Narcolepsy Patient Reported Outcomes Scale
Lead Sponsor:
Boston Children's Hospital
Collaborating Sponsors:
National Jewish Health
Geisinger Clinic
Conditions:
Narcolepsy
Obstructive Sleep Apnea
Eligibility:
All Genders
9-17 years
Brief Summary
The purpose of this study is to test a pediatric narcolepsy patient reported outcomes tool to assess pediatric narcolepsy symptoms and their effect on daily functioning and quality of life. The goal i...
Detailed Description
WHO IS ELIGIBLE? * Children and adolescents with narcolepsy between the ages of 9-17 years * Diagnosis must be verified by a signed letter from physician in order to participate * Participants must b...
Eligibility Criteria
Inclusion
- Children and adolescents ages 9-17
- Have a diagnosis of narcolepsy type 1, narcolepsy type 2, or mild to moderate obstructive sleep apnea (OSA)
Exclusion
- A history of visual or hearing impairment
- A co-morbid neurodevelopmental disorder such as autism or schizophrenia
- No access to computer/tablet/smart phone to complete questionnaires
Key Trial Info
Start Date :
April 2 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 30 2024
Estimated Enrollment :
212 Patients enrolled
Trial Details
Trial ID
NCT05373979
Start Date
April 2 2019
End Date
May 30 2024
Last Update
February 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Children's Hospital
Boston, Massachusetts, United States, 02115